Thai study success affects ongoing placebo trials.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007743:Labor, Obstetric; D019829:Nevirapine / Q000627:therapeutic use; D010919:Placebos; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D013785:Thailand; D015215:Zidovudine / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D010919:Placebos; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019829:Nevirapine